Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

RDHL

RDHL News

Newswire

07:21

Redhill Biopharma shares surge 12.03% premarket after positive opaganib-venetoclax CLL study shows 50% cell reduction.

07:09

Venetoclax Resistance Emerges as Challenge in CLL Therapy, SPHK2 Inhibition Shows Promise

07:05

RedHill Biopharma regains Nasdaq compliance with Talicia partnership.

20:11

IntelGenx, RedHill Biopharma announce European marketing application for RIZAPORT.

06:54

Redhill Biopharma shares jump 45.37% premarket after securing $10.5 million court judgment against Kukbo.

View More

About RDHL

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More